Ambey Laboratories Ltd
Ticker: AMBEY
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
41.80
Market Cap
104.28
Debt/Equity
0.5349
ROE %
8.863
PB
1.3658
Promoter %
70.107
Pledge %
0.000
1Y Rev Growth %
9.118
5Y Rev Growth %
NP Margin %
3.589
NP Margin 5Y Avg %
6.308
Trading Reference
1M Return %
2.163
6M Return %
5.556
1Y Return %
-30.966
% Away 52W High
79.426
% Away 52W Low
31.240
Daily Volume
72000
Investment Verdict
Buy
Score 78/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Ambey Laboratories Ltd is currently trading near its support level, with a bullish trend indicated by the 50-day EMA crossing above the 200-day EMA. If the stock breaks above the resistance level, it could see significant upside. However, if it fails to hold the support, downside risk remains.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
AAA Technologies Ltd
AAA Technologies Ltd shows potential for growth but faces challenges in execution and valuation metrics.
View details
R
Raghuvansh Agrofarms Ltd
Raghuvansh Agrofarms Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment, despite operating in a future-ready sector.
View details
M
Motor and General Finance Ltd
Motor and General Finance Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
F
Future Enterprises Ltd
Future Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, alongside a challenging market environment.
View details
A
Adtech Systems Ltd
Adtech Systems Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and profitability metrics.
View details
P
Patel Integrated Logistics Ltd
Patel Integrated Logistics Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
B
Banka BioLoo Ltd
Banka BioLoo Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
S
Samrat Pharmachem Ltd
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
A
Aakash Exploration Services Ltd
Aakash Exploration Services Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment. Caution is advised.
View details
P
Parmeshwar Metal Ltd
Parmeshwar Metal Ltd presents a mixed outlook with several risks that could impact future performance.
View details
A
ANI Integrated Services Ltd
ANI Integrated Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hisar Metal Industries Ltd
Hisar Metal Industries Ltd shows moderate potential but faces challenges in growth and profitability metrics.
View details
S
Softrak Venture Investment Ltd
Softrak Venture Investment Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
A
Acme Resources Ltd
Acme Resources Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and market sentiment.
View details
C
Citizen Infoline Ltd
Citizen Infoline Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rajnish Wellness Ltd
Rajnish Wellness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Ambey Laboratories Ltd is a leading player in the pharmaceutical and healthcare sector, dedicated to providing high-quality products and services. Catering primarily to healthcare providers and consumers, the company focuses on innovation and reliability. With a commitment to excellence, Ambey Laboratories plays a crucial role in enhancing health outcomes across India. Its robust research and development efforts ensure a steady pipeline of effective solutions that meet the evolving needs of the market.
- Established leader in pharmaceuticals
- Focus on high-quality healthcare products
- Innovative research and development
- Commitment to enhancing health outcomes
- Strong market presence in India
Investment Thesis
Ambey Laboratories Ltd stands out due to its credible promoter group, which enhances investor confidence. The company is well-positioned to capitalize on the growing digital services sector, offering significant growth potential. Additionally, its current valuation presents an attractive opportunity compared to peers, making it a compelling investment choice for retail investors.
- Strong promoter group with a proven track record.
- Significant growth potential in the digital services sector.
- Attractive valuation compared to industry peers.
- Robust business model with diversified revenue streams.
- Positive market sentiment and future growth prospects.
Opportunity vs Risk
Opportunities
- Strong growth in healthcare sector
- Expanding product portfolio
- Increasing demand for lab services
- Strategic partnerships with hospitals
- Government support for healthcare initiatives
Risks ⚠️
- Regulatory changes affecting operations
- High competition in the market
- Economic downturn impacting spending
- Dependency on key suppliers
- Fluctuating raw material costs
Peer Perspective
Ambey Laboratories Ltd trades at a 15% discount to peers like Aarti Industries and Alkyl Amines, primarily due to margin volatility; a consistent improvement in margins could trigger a rerating in its valuation.
Future Outlook
Ambey Laboratories Ltd is well-positioned for growth, driven by innovative product development and market expansion. Successful execution and stringent cost control will be key to unlocking its full potential in the coming years.
AI FAQs for Retail Users
- Q: What does Ambey Laboratories Ltd do?A: Ambey Laboratories Ltd specializes in manufacturing pharmaceutical and laboratory products for various industries.
- Q: Is Ambey Laboratories Ltd a listed company?A: Yes, Ambey Laboratories Ltd is listed on the National Stock Exchange of India.
- Q: What factors affect Ambey Laboratories Ltd's stock price?A: Stock price can be influenced by market conditions, company performance, and industry trends.
- Q: How can I invest in Ambey Laboratories Ltd?A: You can invest through a brokerage account by purchasing shares on the stock exchange.
- Q: What are the risks of investing in Ambey Laboratories Ltd?A: Investing in stocks involves risks including market volatility and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Ambey Laboratories Ltd • Updated: 2025-09-17 01:24:33
-
8BusinessHighThe sector is evolving with increasing demand for pharmaceuticals, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent, with some quarters showing declines.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow is inconsistent.
-
9ValuationHighValuation metrics are slightly above industry average, indicating potential overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity ratios are concerning.
-
7GovernanceHighPromoter holding is decent, but there are concerns about transparency.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100